Compare
Addentax Group Corp. vs ADM Endeavors, Inc. vs Asiafin Holdings Corp. vs BioScience Health Innovations, Inc.
| Latest fiscal year | Addentax Group Corp. ATXG | ADM Endeavors, Inc. ADMQ | Asiafin Holdings Corp. ASFH | BioScience Health Innovations, Inc. BHIC |
|---|---|---|---|---|
| Year ended | 2026-03-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $5.37M | $5.62M | $5.13M | $5.69M |
| Revenue growth (YoY) | +28.5% | -2.4% | +51.6% | +208.3% |
| Gross margin | 14.1% | n/a | 37.1% | 57.0% |
| Operating margin | -28.5% | 4.4% | 0.8% | 12.6% |
| Net margin | -83.2% | 8.6% | -1.7% | 11.3% |
| Net income | -$4.47M | $486.3K | -$85.3K | $642.1K |
| EPS (Diluted) | -$6.27 | $0.00 | $0.00 | $0.06 |
| Operating cash flow | -$603.6K | $381.1K | $503.9K | $172.2K |
| Free cash flow | -$784.5K | -$3.18M | $394.6K | n/a |
| Cash & equivalents | $574.3K | n/a | $1.75M | $661.9K |
| Total assets | $29.25M | $10.88M | $4.75M | $1.71M |
| Total liabilities | $7.57M | $7.28M | $2.19M | $229.9K |
| Shareholders' equity | $21.80M | $3.60M | $2.57M | $1.48M |
| Return on year-end equity | -20.5% | 13.5% | -3.3% | 43.5% |
| Shares outstanding | 781.3K | 158.52M | 81.92M | 10.98M |
Revenue, most recent five fiscal years
| Fiscal year | Addentax Group Corp. | ADM Endeavors, Inc. | Asiafin Holdings Corp. | BioScience Health Innovations, Inc. |
|---|---|---|---|---|
| Latest | $5.37M Ended 2026-03-31 | $5.62M Ended 2025-12-31 | $5.13M Ended 2025-12-31 | $5.69M Ended 2025-12-31 |
| 1 year earlier | $4.18M Ended 2025-03-31 | $5.76M Ended 2024-12-31 | $3.38M Ended 2024-12-31 | $1.84M Ended 2024-12-31 |
| 2 years earlier | $5.15M Ended 2024-03-31 | $5.19M Ended 2023-12-31 | $3.11M Ended 2023-12-31 | $597.6K Ended 2023-12-31 |
| 3 years earlier | $7.94M Ended 2023-03-31 | $5.62M Ended 2022-12-31 | n/a | $69.3K Ended 2022-12-31 |
| 4 years earlier | $12.69M Ended 2022-03-31 | $6.56M Ended 2021-12-31 | n/a | n/a |